Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: THE JOHNS HOPKINS UNIVERSITY
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-06-01 to 2024-09-30
Current total value of award: $100615
Description: PHASE I STUDY OF THE INFECTIVITY, SAFETY AND IMMUNOGENICITY OF A RECOMBINANT, LIVE-ATTENUATED, BOVINE/HUMAN, PARAINFLUENZA VIRUS TYPE 3 (B/HPIV3) VECTOR VACCINE EXPRESSING THE SPIKE GLYCOPROTEIN OF SARS-COV-2, DELIVERED BY NASAL SPRAY TO HPIV3-SEROPO